Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040768 | SCV000064459 | likely benign | not specified | 2012-01-31 | criteria provided, single submitter | clinical testing | p.Asn27640Asn in exon 284 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 3/6690 European American chromosomes and 1/3214 African American chromosomes by the NHLBI Exome sequencing project in a broad population (http://evs.gs.washington.edu/EVS). |
Invitae | RCV001083455 | SCV000286904 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000251412 | SCV000318994 | likely benign | Cardiovascular phenotype | 2013-10-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000727784 | SCV000515179 | likely benign | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727784 | SCV000855181 | uncertain significance | not provided | 2017-09-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000727784 | SCV000884801 | likely benign | not provided | 2019-08-13 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769888 | SCV000901314 | likely benign | Cardiomyopathy | 2019-09-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727784 | SCV004150235 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Clinical Genetics, |
RCV000040768 | SCV001923608 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000727784 | SCV001928983 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000727784 | SCV001965046 | likely benign | not provided | no assertion criteria provided | clinical testing |